Early cancer detection
Targeted cancer treatment

bioAffinity Technologies applies experience, intelligence, collaboration, and creativity to the global fight against cancer. We know that by unlocking our personal potential, we make discoveries that give others an opportunity to live longer and more enjoyable lives.

Cancer starts at the cellular level. That’s where CyPath® finds it.

Non-invasive, early-stage cancer diagnostics and targeted therapeutics

A longer and more enjoyable life

Our innovative scientific research results in non-invasive diagnostics and advanced treatments in the fight against cancer.

Early Detection of Cancer and Targeted Treatment Saves Lives

Addressing a critical need to find cancer early and treat cancer specifically bioAffinity Technologies, Inc. develops tests and therapies to detect and treat cancer at the cellular level. Our first product, CyPath® Flow Cytometry for Lung Cancer (CyPath® Lung), has been licensed by Precision Pathology Services for continued development and commercial sale as a Laboratory Developed Test.

learn more

CyPath® uses a porphyrin molecule that displays an unusually high affinity to bind to cancer cells that fluoresce brightly when labeled to distinguish cancer from non-cancer cells using flow cytometry. Our innovative scientific research results in non-invasive diagnostics and advanced treatments in the fight against cancer. This animated video produced by the Massachusetts Institute of Technology (MIT) Star CellBio introduces flow cytometry, a technique in which cells suspended in a fluid flow one at a time through a focus of exciting light, which is scattered in patterns characteristic to the cells and their components. Cells are labeled with fluorescent markers so that light is first absorbed and then emitted at altered frequencies. A sensor detecting the scattered or emitted light measures the size and molecular characteristics of individual cells. Tens of thousands of cells can be examined per minute and the data gathered is processed by computer.

learn more